Newsfiscal.ai
Akebia Therapeutics Announces Positive Data from VOICE Trial of Vafseo
· Published
Article summary
Akebia Therapeutics reported positive results from the Vafseo Outcomes In-Center Experience (VOICE) trial, demonstrating improved safety outcomes for dialysis patients treated with vadadustat.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…